UNSPSC 51143004: Amifampridine

This classification denotes a cation channel blocker with the molecular formula C5H7N3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RU4S6E2G0J, chemically known as 3,4 DIAMINOPYRIDINE, but generally known as amifampridine. European Medicines Agency schedules amifampridine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB28846. As of Q4 2014, AMIFAMPRIDINE remains the US FDA Preferred Term for this commodity. Amifampridine bears US NLM identifiers UMLS ID C0046948 and NCI Concept Code C82687.

SMILES: none.

UNSPSC 51143004 Amifampridine is a Commodity code for a potassium-channel blocking agent used in the treatment of Lambert-Eaton myasthenic syndrome, acquired myasthenia gravis, and related neuromuscular disorders. State and local procurement activity under this code reflects purchasing by health departments, Medicaid agencies, county hospitals, and correctional-health systems acquiring this specialized pharmaceutical for patient populations with qualifying conditions.

The source provided contains no recent state or local contract opportunities under this code, and therefore does not support characterization of active issuing bodies, geographic concentration, or representative solicitations.